Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
65.08B | 61.56B | 58.80B | 54.34B | 41.44B | 41.23B | Gross Profit |
33.38B | 30.99B | 30.41B | 27.33B | 18.36B | 17.55B | EBIT |
21.91B | 19.80B | 20.14B | 18.21B | 10.25B | 9.35B | EBITDA |
26.41B | 23.94B | 23.23B | 20.79B | 12.09B | 11.07B | Net Income Common Stockholders |
16.87B | 15.22B | 15.02B | 13.35B | 6.93B | 5.89B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
55.25B | 55.25B | 49.80B | 44.62B | 34.09B | 29.33B | Total Assets |
122.52B | 122.52B | 108.03B | 95.90B | 78.06B | 70.68B | Total Debt |
400.00M | 400.00M | 733.00M | 1.70B | 1.97B | 2.10B | Net Debt |
-54.85B | -54.85B | -49.06B | -42.92B | -32.12B | -27.23B | Total Liabilities |
13.31B | 13.31B | 13.82B | 16.22B | 11.72B | 11.23B | Stockholders Equity |
109.20B | 109.20B | 94.21B | 79.68B | 66.34B | 59.45B |
Cash Flow | Free Cash Flow | ||||
4.22B | 5.90B | 6.92B | 10.95B | 5.14B | 5.28B | Operating Cash Flow |
4.22B | 17.22B | 15.65B | 14.76B | 10.71B | 10.72B | Investing Cash Flow |
0.00 | -10.81B | -8.76B | -3.52B | -5.38B | -5.27B | Financing Cash Flow |
0.00 | -1.36B | -1.88B | -1.13B | -801.92M | 1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $3.70T | 18.29 | 7.94% | 2.48% | 7.80% | -3.16% | |
71 Outperform | ¥317.82B | 17.11 | 16.34% | 0.35% | 17.60% | 35.70% | |
68 Neutral | $825.77B | 9.33 | 13.60% | 3.93% | 7.52% | 19.95% | |
66 Neutral | $576.37B | 12.24 | 9.16% | 2.72% | 3.01% | 61.47% | |
66 Neutral | $469.77B | 10.28 | 6.79% | 3.63% | 7.97% | 31.70% | |
59 Neutral | $9.97B | 10.09 | -6.54% | 3.08% | 7.41% | -11.60% | |
47 Neutral | ¥14.56B | 451.94 | ― | -4.30% | ― |